PanoramicaGraficoNotizieSchermataTrader

Morgan Stanley Knock-Out PPGN/  DE000MG14L25  /

Stuttgart
11/11/2024  16:59:04 Var.-0.010 Denaro22:00:39 Lettera22:00:39 Sottostante Prezzo di esercizio Expiration date Tipo di opzione
0.540EUR -1.82% -
Quantità in denaro: -		 -
Quantità in lettera: -		 POLYPEPTIDE N 26.0135 CHF 31/12/2078 Call
GlobeNewswire 31/08 Junshi Biosciences Announces 2024 Interim Financial Results and Provides Corporate Updates
GlobeNewswire 13/08 Meso Numismatics, a Renowned Leader in Regenerative Medical, Announces Global Stem Cells Groups (GSC...
GlobeNewswire 08/08 ProQR Announces Second Quarter 2024 Operating and Financial Results
GlobeNewswire 05/08 Terns Pharmaceuticals Reports Second Quarter 2024 Financial Results and Corporate Updates
GlobeNewswire 08/07 Truveta’s real-world data study comparing tirzepatide (Mounjaro) and semaglutide (Ozempic) for weigh...
GlobeNewswire 05/06 Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at th...
GlobeNewswire 13/05 Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Updates
GlobeNewswire 09/05 ProQR Announces First Quarter 2024 Operating and Financial Results
GlobeNewswire 08/05 ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer™ RNA Editing Program Targeting...
GlobeNewswire 29/03 Junshi Biosciences Announces 2023 Full Year Financial Results and Provides Corporate Updates
GlobeNewswire 14/03 Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Upda...
GlobeNewswire 13/03 ProQR Announces Year End 2023 Operating and Financial Results
GlobeNewswire 05/03 Gain Therapeutics Presents Data at the AD/PD™ 2024 Conference Demonstrating the Mechanism of Action ...
GlobeNewswire 10/01 NORDICUS PARTNERS CORPORATION ENTERS INTO A CONSULTANCY AGREEMENT WITH OROCIDIN A/S IN DENMARK
GlobeNewswire 04/01 Terns Pharmaceuticals to Highlight 2024 Priorities and Clinical Milestones at the 42nd Annual J.P. M...
GlobeNewswire 14/12/2023 Vandria Announces $20.6M (CHF18M) Series A Financing Led by ND Capital to Drive CNS Clinical Program...
GlobeNewswire 01/12/2023 Gain Therapeutics Announces Preclinical Data Showing Restoration of Enzymatic Function with Novel Al...
GlobeNewswire 27/11/2023 Largest real-world study finds tirzepatide (Mounjaro) up to three times more effective than semaglut...
GlobeNewswire 07/11/2023 ProQR Announces Third Quarter 2023 Operating and Financial Results
GlobeNewswire 02/11/2023 Terns Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of TERN-601 Oral G...
GlobeNewswire 02/10/2023 Assembly Biosciences Nominates Development Candidate ABI-6250, an Orally Bioavailable HDV Entry Inhi...
GlobeNewswire 19/09/2023 Assembly Biosciences to Highlight Pipeline Progress in HBV and HDV at the 2023 International HBV Mee...
GlobeNewswire 31/08/2023 Junshi Biosciences Announces 2023 Interim Financial Results and Provides Corporate Updates
Newsfile Corp 16/08/2023 Polypeptide.ltd Announces Intent to Expand Tirzepatide and Retatrutide to Production Capacity of Hig...
Newsfile Corp 01/05/2023 KeraFactor(TM) Introduces an Unprecedented Laser-Assisted Topical Delivery Solution